Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 06, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.19 $229.95
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 4

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,325

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 05, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.19 $43.80
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 3

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,268

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 05, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.19 $67.89
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 3

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,719

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 05, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.19 $142.35
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 3

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,001

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 05, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.19 $229.95
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 3

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,220

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 02, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.31 $46.20
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 2

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,248

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 02, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.31 $71.61
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 2

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,688

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 02, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.31 $150.15
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 2

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,936

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 02, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.31 $242.55
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 2

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,115

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 01, 2022 Filed Dec 23, 2022 22:13 UTC PurchaseCommon Stock 20 $2.33 $46.60
Disclosure

SEC source: 0001209191-22-062657 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,228

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 01, 2022 Filed Dec 23, 2022 22:11 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.33 $72.23
Disclosure

SEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,657

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 01, 2022 Filed Dec 23, 2022 22:10 UTC PurchaseCommon Stock 65 $2.33 $151.45
Disclosure

SEC source: 0001209191-22-062651 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,871

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
December 01, 2022 Filed Dec 23, 2022 22:07 UTC PurchaseCommon Stock 105 $2.33 $244.65
Disclosure

SEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,010

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 30, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.32 $46.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 21

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,208

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 30, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.32 $71.92
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 21

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,626

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 30, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.32 $150.80
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 21

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,806

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 30, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.32 $243.60
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 21

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,905

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 29, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.34 $46.80
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 20

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,188

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 29, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.34 $72.54
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 20

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,595

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 29, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.34 $152.10
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 20

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,741

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 29, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.34 $245.70
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 20

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,800

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 28, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.37 $47.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 19

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,168

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 28, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.37 $73.47
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 19

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,564

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 28, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.37 $154.05
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 19

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,676

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 28, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.37 $248.85
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 19

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,695

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 25, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.31 $46.20
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 18

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,148

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 25, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.31 $71.61
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 18

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,533

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 25, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.31 $150.15
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 18

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,611

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 25, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.31 $242.55
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 18

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,590

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 23, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.29 $45.80
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 17

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,128

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 23, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.29 $70.99
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 17

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,502

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 23, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.29 $148.85
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 17

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,546

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 23, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.29 $240.45
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 17

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,485

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 22, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.37 $47.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 16

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,108

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 22, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.37 $73.47
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 16

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,471

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 22, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.37 $154.05
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 16

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,481

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 22, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.37 $248.85
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 16

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,380

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 21, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.38 $47.60
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 15

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,088

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 21, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.38 $73.78
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 15

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,440

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 21, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.38 $154.70
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 15

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,416

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 21, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.38 $249.90
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,275

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 18, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.27 $45.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 14

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,068

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 18, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.27 $70.37
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 14

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,409

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 18, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.27 $147.55
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 14

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,351

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 18, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.27 $238.35
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,170

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 17, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.29 $45.80
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 13

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,048

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 17, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.29 $70.99
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 13

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,378

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 17, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.29 $148.85
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 13

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,286

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 17, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.29 $240.45
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 13

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,065

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 16, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.31 $46.20
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 12

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,028

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.